🔗 Permalink

Inventor profile of:

Christian LECHNER

City:

Berlin

Country:

Germany

Published Applications:

Last publication date:

2026-02-05

Top Assignees for applications by Christian LECHNER

The entities that hold a legal rights for patent applications filed by inventor LECHNER Christian:

Bayer Aktiengesellschaft 9 Leverkusen, Germany
THE BROAD INSTITUTE, INC. 5 Cambridge, MA United States
Dana-Farber-Cancer Institute, Inc. 5 Boston, MA United States
Deutsches Krebsforschungszentrum 4 Heidelberg, Germany
Bayer Pharma Aktiengesellschaft 4 Berlin, Germany
Bayer Pharma Aktiengesellschaft 1 , Germany
Deutsches Krebsforschungszentrum 1 , Germany
Bayer Aktiengesellschaft 1 , Germany

Recent patent applications by LECHNER Christian

Christian LECHNER from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-05

US20260035365A1

Chemistry; metallurgy

1H-PYRROLO[3,2-B]PYRIDINE DERIVATIVES AS IRREVERSIBLE INHIBITORS OF MUTANT EGFR FOR THE TREATMENT OF CANCER

#2 | 2025-03-20

US20250092014A1

Chemistry; metallurgy

COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE

#3 | 2024-05-09

US20240150277A1

Chemistry; metallurgy

Covalent PPARG inverse-agonists

#4 | 2024-04-04

US20240109850A1

Chemistry; metallurgy

Covalent PPARG inverse-agonists

#5 | 2023-11-16

US20230365554A1

Chemistry; metallurgy

SUBSTITUTED PYRROLO-PYRIDINONE DERIVATIVES AND THERAPEUTIC USES THEREOF

#6 | 2023-10-26

US20230339939A1

Chemistry; metallurgy

SUBSTITUTED 1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS AND METHODS OF USE THEREOF

#7 | 2023-06-29

US20230201186A1

Human necessities

Substituted aminoquinolones as DGKalpha inhibitors for immune activation

#8 | 2023-05-11

US20230148194A1

Human necessities

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION

#9 | 2023-03-02

US20230064809A1

Human necessities

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION

#10 | 2023-03-02

US20230062100A1

Human necessities

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION

#11 | 2023-02-16

US20230046077A1

Chemistry; metallurgy

3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors

#12 | 2021-01-21

US20210017174A1

Chemistry; metallurgy

IDENTIFICATION AND USE OF ERK5 INHIBITOR

InventorID:

4979829 ⎘